In addition, ghrelin and its agonists promote gastric emptying and increase plasma levels of levodopa (L-dopa) and dopamine, which may be utilized for alleviating gastrointestinal problems that appear after PD and L-dopa treatment [237]. The gene discussed is GHRL; the disease is Parkinson disease.